BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Lexicon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:26 pm Sale |
2024-09-30 | 13G | Lexicon Pharmaceuticals, Inc. LXRX |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-24,435,632 (Position Closed) |
Filing |
| 2024-02-14 09:37 am Purchase |
2023-12-31 | 13G | Lexicon Pharmaceuticals, Inc. LXRX |
BIOTECHNOLOGY VALUE FUND L P | 24,435,632 9.980% |
8,286,453 (+51.31%) |
Filing |
| 2023-02-13 6:20 pm Purchase |
2022-12-31 | 13G | Lexicon Pharmaceuticals, Inc. LXRX |
BIOTECHNOLOGY VALUE FUND L P | 16,149,179 8.600% |
1,789,179 (+12.46%) |
Filing |
| 2022-02-11 8:33 pm Purchase |
2021-12-31 | 13G | Lexicon Pharmaceuticals, Inc. LXRX |
BIOTECHNOLOGY VALUE FUND L P | 14,360,000 9.600% |
3,397,000 (+30.99%) |
Filing |
| 2020-12-21 4:37 pm Purchase |
2020-12-11 | 13G | Lexicon Pharmaceuticals, Inc. LXRX |
BIOTECHNOLOGY VALUE FUND L P | 10,963,000 7.800% |
10,963,000 (New Position) |
Filing |